Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.9
59.56%
60%
—
33.32%
20%
—
5 Years
Score4.9
Net Growth59.56%
Net Trend60%
Net Income Consistency—
Rev Growth33.32%
Rev Trend20%
Revenue Consistency—
Ensysce Biosciences Inc fundamental performance
Between 2020 and 2025, revenue grew from $ 3M to $ 5M and net income went from $ 56.77K to -$ 10M. Revenue increased in 1 of those 5 years; net income in 3.
Ensysce Biosciences Inc currently holds a 5-year HDB Score of 4.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-13 | $ 0.35 | — |
1 Year2025-08-13 | $ 2.15 | -83.79% |
5 Years2021-08-13 | $ 11.81K | -100.00% |
All Time2018-02-26 | $ 34.74K | -100.00% |
| Period | Last Price2026-08-13 | 1 Year2025-08-13 | 5 Years2021-08-13 | All Time2018-02-26 |
|---|---|---|---|---|
| Price | $ 0.35 | $ 2.15 | $ 11.81K | $ 34.74K |
| Return | — | -83.79% | -100.00% | -100.00% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 4M | -$ 11M | $ 745.48K |
| 2025 | $ 5M | -$ 10M | $ 4M |
| 2024 | $ 5M | -$ 7M | $ 3M |
| 2023 | $ 2M | -$ 10M | $ 1M |
| 2022 | $ 2M | -$ 24M | $ 3M |
| 2021 | $ 3M | -$ 29M | $ 12M |
| 2020 | $ 3M | $ 56.77K | $ 194.21K |
| 2019 | $ 1M | $ 1M | $ 1M |
| IPO2018 | $ 0.00 | $ 2M | $ 1M |
Explore beyond ENSC
You're looking at Ensysce Biosciences Inc. Members apply the same fundamental framework across all 3,859 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,859 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
